NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”
In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes
Komen Foundation Shifts Emphasis To Underserved
Clinton Budget For NIH “Disappointing,” AACR executive Director Says
ACS Expresses Concern About “Fletcher Report” On Mammography
FDA Ceases Exclusion Of Women From Early Drug Studies
ACS Encourages Grant Applications In All Aspects Of Pain Control
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”